Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.

Slides:



Advertisements
Similar presentations
Information technology for surveillance Can information tools improve surveillance? Denis Coulombier ECDC.
Advertisements

The Roadmap to Successful Xpert Implementation - 37 steps -
Improving diagnosis TB laboratory strengthening.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
An Introduction to HIV Incidence Surveillance (HIS) in California California Department of Public Health Office of AIDS.
Module 9 Part A: Monitoring and Evaluation *Image courtesy of: World Lung Foundation.
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Monitoring and Evaluation: Tuberculosis Control Programs
An Introduction to Monitoring and Evaluation for National TB Programs.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Introduction to Monitoring and Evaluation for National TB Programs 20 September 2005.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Monitoring and Evaluation for TB Programs
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Indicators, Data Sources, and Data Quality for TB M&E
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Monitoring and Evaluation for TB Programs Developing a Monitoring and Evaluation Plan Charlotte Colvin 2 February 2006 New Delhi, India.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
1 Interpretation and use. 2 The walls inside are plastered with laboriously made graphs…
1 Module ON-SITE SUPERVISION OVERVIEW. 2 Content Overview What is on-site supervision? Advantages and disadvantages of on-site supervision Organization.
Monitoring and Evaluation Module 12 – March 2010.
Cases and Rates in 1991 Table 6 Population: ? New SM +: N = 8,507 All Cases: N = 10,903 Table 8 Population: ? New SM +: N = 8,835 All cases: N = 10,872.
Monitoring Drug Resistant Tuberculosis Treatment in Brazil through an Innovative Web-based Information System Dr. Luis Gustavo Bastos Management Sciences.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
1 Data analysis. 2 Turning data into information.
U pdates on the development of the NTP National Strategic Plan GC National TB Conference Pokhara, July 14-15, 2014 Giampaolo Mezzabotta Medical.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Primer on Monitoring and Evaluation. The 3 Pillars of Monitoring and Evaluation  Identifying the Performance Indicators  Collecting information using.
Orientation on HIV care and ART Recording and Reporting System.
October 20, 2015 UNAIDS Monitoring and Evaluation of HIV Programs for MSM Linking data to Program Planning, Implementation, and Advocacy UNAIDS/S.NOORANI.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
PREVALENCE OF MDR-TB AMONGST PATIENTS WITH HIV AND TB CO- INFECTION SEEN AT THE DOTS CLINIC OF N.I.M.R., LAGOS, NIGERIA. Enya V.N.V, Onubogu C.C., Wahab.
SUB-MODULE 5. MEANS OF VERIFICATION RESULTS BASED LOGICAL FRAMEWORK TRAINING Quality Assurance and Results Department (ORQR.2)
Indicators for ACSM.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Unit 6: Specialised Techniques: Anti-Microbial Resistance Monitoring and Assessment of STI Syndrome Aetiologies #4-6-1.
Quality Assurance Programme of the Canadian Census of Population Expert Group Meeting on Population and Housing Censuses Geneva July 7-9, 2010.
Name of LGU Accomplishment Report NTP Year-End Evaluation and Planning Workshop November 23-27, 2009.
Principles and Structure of a Research Protocol Anthony Harries The Union, Paris, France.
DATA SOURCES FOR MEASURING FORCED DISPLACEMENT WITH A FOCUS ON ADMINISTRATIVE SOURCES Khassoum DIALLO Snr Statistician UNHCR Regional workshop on strengthening.
Session 2: Developing a Comprehensive M&E Work Plan.
NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February
Roundtable. Detection and treatment of TB Andrew Black.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Developing Program Indicators Measuring Results MEASURE Evaluation.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Introduction to Monitoring and Evaluation of National Tuberculosis Programs Lisa V. Adams, MD E&E Regional Workshop Kiev, Ukraine May 23-26, 2006.
Monitoring and Evaluation: A Review of Terms
Monitoring and Evaluation Frameworks
World Tuberculosis Day 2014
Philippe Glaziou Geneva, 12 October 2009
11 ii. Develop a plan for aDSM
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
Targets and Indicators Monitoring and Evaluation
National Tuberculosis Control Program in Vietnam
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
EXERCISE 11: Computing and Analyzing Program Indicators
Issues on the current information system
Surveillance, Monitoring and Evaluation Working Group
Indicators, Data Sources and Data Quality for TB M&E
Presentation transcript:

Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs

Table of Contents Introduction Defining M&E M&E for National TB Programs Indicators Appendices

Indicator Selection Detailed description for each indicator –Definition –What it measures –How to measure it –Data sources –Frequency and function –Strengths and limitations

Definition Type of indicator Numerator and Denominator Yes/No Brief review of criteria for assessment

What it measures Relevance to program management –Identifying problems, solutions –Making decisions Key program operation “captured” by the indicator Possible interpretation of results –Is the NTP reaching its goals? –What does a low or high value mean for the NTP?

How to measure it Source of numerator and denominator Detailed criteria for assessment of qualitative indicators –Is it a “Yes” or “No”? How to perform the calculation

Data sources Census data Monthly, quarterly, and annual reports from each level of the NTP Registers – cough/TB suspects, TB cases, laboratory Treatment cards Program documentation –Stock cards, distribution records, meeting reports, annual reports

Frequency and function How often indicator should be reported –Monthly, Quarterly, Annually, two to three years Who should receive reports –Administrative levels within NTP –Donor agencies –Key partners in TB-control activities Monitoring or evaluation? –Appropriate use of indicator

Strengths and weaknesses How accurately does the indicator measure achievement or implementation of a key DOTS component? Are the data easy or difficult to locate? Proceeding with caution…

Examples Indicator 4.1 – Surveillance of MDR-TB Indicator 2.2 – Case-notification rate – new smear-positive pulmonary-TB cases

Indicator 1.4 Surveillance of MDR-TB Definition “The national TB-control program assesses the prevalence of MDR-TB at least once within a 5-year period. This is a yes/no indicator.” Qualitative indicator (yes/no) Basic criteria for determining response

What it measures Availability of information on drug susceptibility Program quality –Are treatment regimens effective? –Can the NTP estimate the burden of MDR-TB? –Can the NTP plan for DOTS-Plus program?

Data sources Reports or other documentation of national or sub-national surveys of MDR-TB following protocols/quality assurance recommended by WHO & IUATLD

Data sources NTP data and reports

Frequency and Function If “no,” an indicator should be measured every year until it is a “yes.” If “yes,” an indicator should be periodically assessed (every 2 to 5 years) to ensure the activity continues. This indicator is appropriate for NTP program reviews.

Strengths & Limitations Useful for planning and monitoring Easy to measure BUT… Quality of MDR-TB surveillance? Limited policy/NTP response to finding of MDR-TB

Indicator 2.2 Case notification rate-new smear positive pulmonary TB cases Definition “The number of new smear-positive pulmonary-TB cases reported to the NTP per year per 100,000 population.” Numerator & denominator Calculation

What it measures Information on burden of infectious cases Detection of weaknesses in case detection and registration Useful to describe trends – program coverage, prevalence, impact of HIV co- infection Data for program planning Useful to disaggregate by age group and gender

How to measure it The numerator can be found in national level reports for the previous year The denominator should be available from census data  Definition of “notified” may vary by context

Data sources Quarterly reports on TB case-detection Census statistics

Frequency & Function This indicator should be calculated on an annual basis. This is a routinely reported indicator.  This may vary by context; annual reporting is the minimum.

Strengths & Limitations Directly measures NTP capacity to identify infectious cases Easy to compare trends over time Objective measurement (sputum microscopy) BUT… Represents only a subset of cases

Conclusions Indicators are the “CORE” of the Compendium However, Introduction/overview of M&E is also critical information Appendices include tools to facilitate planning for M&E, data collection